Reverse DCF
What growth does the market imply for NEPHROPLUS?
Working backwards from the current price to find the FCF growth assumption baked in.
very aggressive
23.6% implied annual FCF growth
The market is pricing in exceptional growth that only a handful of companies sustain for a decade. For context, this company has historically grown at 18.0%. High execution risk.
Current Price
₹748
Historical Growth
18.0%
FCF Yield
1.51%
Price / FCF
66.3x
Plain English
To justify today's price of ₹748.15, NEPHROPLUS.NS needs to grow its free cash flow at 23.6% per year for the next 10 years. That is 5.6% faster than its historical growth rate of 18.0%. At its historical growth rate, the stock would take 16 years to justify today's price. The market is effectively paying for a perfect future.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| GDP rate | 10.0% | ₹267 | -64.3% |
| Half implied | 11.8% | ₹306 | -59.1% |
| Historical | 18.0% | ₹490 | -34.6% |
| Implied | 23.6% | ₹748 | +0.0% |
At Historical Growth Rate
DCF horizon: 10 years. At 18.0% growth, the model values NEPHROPLUS at ₹490, below today's ₹748.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, reverse DCF, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.